• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.62% Nasdaq Up 1.71%

    More On OXBT

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Tenax Therapeutics, Inc. (OXBT)

    -NasdaqCM
    4.04 Up 0.02(0.50%) Sep 18 - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.04
    Open:4.04
    Bid:N/A
    Ask:N/A
    1y Target Est:10.50
    Beta:0.68
    Next Earnings Date:N/A
    Day's Range:4.00 - 4.11
    52wk Range:1.19 - 9.75
    Volume:188,777
    Avg Vol (3m):214,059
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-1.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OXBT

    Comparison

    Symbol% ChgMkt Cap
    OXBTUp 0.50%N/A
    NVSUp 2.12%227.96B
    PFEUp 2.19%200.36B
    RHHBYUp 2.47%250.94B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback